- Home
- BDX vs DHI Comparison
BDX vs DHI Comparison
Compare BDX & DHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDX | DHI |
|---|---|---|
| Founded | 1897 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.0B | 43.8B |
| IPO Year | 1998 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BDX | DHI |
|---|---|---|
| Price | $176.03 | $145.58 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 14 |
| Target Price | ★ $186.00 | $166.08 |
| AVG Volume (30 Days) | 1.7M | ★ 2.5M |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | ★ 2.89% | 1.19% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.25 | ★ 7.45 |
| Revenue | $21,840,000,000.00 | ★ $34,250,400,000.00 |
| Revenue This Year | N/A | $0.05 |
| Revenue Next Year | $3.02 | $5.85 |
| P/E Ratio | $682.64 | ★ $20.33 |
| Revenue Growth | ★ 8.24 | N/A |
| 52 Week Low | $140.11 | $131.75 |
| 52 Week High | $213.08 | $183.62 |
Technical Indicators
Market Signals| Indicator | BDX | DHI |
|---|---|---|
| Relative Strength Index (RSI) | 72.34 | N/A |
| Support Level | $163.44 | N/A |
| Resistance Level | $196.05 | N/A |
| Average True Range (ATR) | 3.72 | 0.00 |
| MACD | 1.47 | 0.00 |
| Stochastic Oscillator | 96.76 | 0.00 |
Price Performance
Historical ComparisonAbout BDX Becton Dickinson and Company
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
About DHI D.R. Horton Inc.
D.R. Horton is the largest homebuilder in the United States with operations in 126 markets across 36 states. D.R. Horton mainly builds single-family homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. The firm has majority ownership of Forestar Group, a publicly traded residential lot development company. D.R. Horton's headquarters are in Arlington, Texas.